Delivery Order SPE2DB22D3004-SPE2DB24FPD99
Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $8.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGEML. The $31,425.34 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to provide pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. The $57,189.46 contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $20,566.14 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $16,101.43 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563651000 STELARA 90 MG/ML SYRINGEML. The contract has a potential value of $10,478.50 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML. The order has a potential value of $64,397.14 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $6,715.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a wide range of...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of STELARA 90 MG/ML SYRINGE/ML. The contract has a potential value of $9,066.45 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering this pharmaceutical product to support military treatment programs and facilities. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML pharmaceutical products. The contract has a ceiling value of $47,122.86 and a period of performance through April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...